Literature DB >> 15200010

Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery.

S K Jain1, M K Chourasia, A K Jain, R K Jain, A K Shrivastava.   

Abstract

Mucoadhesive drug delivery systems are those that provide intimate contact of the drug with the mucosa for an extended period of time. In our present work, mucoadhesive chitosan microspheres were prepared by emulsion solvent method. Formulations were characterized for various physicochemical attributes, shape, surface morphology, size, and size distribution, drug payload, swelling ability, and mucoadhesion. The effect of drug, citric acid, and permeation enhancer concentration on the physicochemical properties was studied. Crosslinked chitosan microspheres showed very good mucoadhesion, which was decreased on increasing the drug concentration and citric acid concentration, and slightly improved upon incorporation of permeation enhancer. The in vitro drug release and in vitro drug permeability through mucous membrane were performed, and slow release/permeation was noted with chitosan citrate complexed microspheres compared with noncomplexed chitosan microspheres. The in vivo performance of mucoadhesive microspheres formulations showed prolonged and controlled release of salbutamol as compared with oral administration of conventional dosage form.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200010     DOI: 10.1080/10717540490280750

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  6 in total

1.  Programmed Application of Transforming Growth Factor β3 and Rac1 Inhibitor NSC23766 Committed Hyaline Cartilage Differentiation of Adipose-Derived Stem Cells for Osteochondral Defect Repair.

Authors:  Shouan Zhu; Pengfei Chen; Yan Wu; Si Xiong; Heng Sun; Qingqing Xia; Libing Shi; Huanhuan Liu; Hong Wei Ouyang
Journal:  Stem Cells Transl Med       Date:  2014-08-25       Impact factor: 6.940

Review 2.  Controlled delivery systems: from pharmaceuticals to cells and genes.

Authors:  Elizabeth Rosado Balmayor; Helena Sepulveda Azevedo; Rui L Reis
Journal:  Pharm Res       Date:  2011-03-19       Impact factor: 4.200

3.  Tissue Permeability Effects Associated with the Use of Mucoadhesive Cationic Nanoformulations of Docetaxel in the Bladder.

Authors:  Rakhi Pandey; John K Jackson; Clement Mugabe; Richard Liggins; Helen M Burt
Journal:  Pharm Res       Date:  2016-04-18       Impact factor: 4.200

4.  Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development in vivo.

Authors:  Shouan Zhu; Ping Lu; Huanhuan Liu; Pengfei Chen; Yan Wu; Yanyan Wang; Heng Sun; Xiaolei Zhang; Qingqing Xia; Boon Chin Heng; Yiting Zhou; Hong Wei Ouyang
Journal:  Ann Rheum Dis       Date:  2013-11-20       Impact factor: 19.103

5.  Preparation and evaluation of Levosalbutamol sulphate chitosan microsphere for the treatment of asthma.

Authors:  D Dinal Patel; V Nirav Patel; T Vaishali Thakkar; R Tejal Gandhi
Journal:  J Pharm Bioallied Sci       Date:  2012-03

6.  Targeting Anion Exchange of Osteoclast, a New Strategy for Preventing Wear Particles Induced- Osteolysis.

Authors:  Chuanlong Wu; Xuqiang Liu; Ruixin Sun; Yunhao Qin; Zhiqing Liu; Shengbing Yang; Tingting Tang; Zhenan Zhu; Degang Yu; Fengxiang Liu
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.